Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients

NCT01308944 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Invasive Epithelial Ovarian Cancer
Primary Peritoneal Carcinoma
Fallopian Tube Cancer

Interventions

DRUG: Propranolol

Sponsor

Washington University School of Medicine